|
|
|
Insider
Information: |
Casdin Eli |
Relationship: |
Director |
City: |
Madison |
State: |
WI |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
18,894,431 |
|
Indirect Shares
|
147,334,950 |
|
|
Direct
Value |
$204,486,367 |
|
|
Indirect Value
|
$2,242,116,487 |
|
|
Total
Shares |
166,229,381 |
|
|
Total
Value |
$2,446,602,855 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
20
|
2
|
Stock
price went up :
|
10
|
0
|
Stock
price went down : |
10
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
23.8%
|
-48.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Exact Sciences Corp |
EXAS |
Director |
2020-07-23 |
8,820 |
2020-07-23 |
450 |
Premium* |
|
Fulcrum Therapeutics, Inc. |
FULC |
10% Owner |
2019-07-22 |
0 |
2019-07-22 |
604,285 |
Premium* |
|
Biolife Solutions Inc |
BLFS |
10% Owner |
2024-04-30 |
8,707,165 |
2024-04-30 |
0 |
Premium* |
|
Generation Bio Co. |
GBIO |
10% Owner |
2020-06-16 |
0 |
2020-06-16 |
1,611,215 |
Premium* |
|
Century Therapeutics, Inc. |
IPSC |
Director |
2021-06-22 |
0 |
2021-06-22 |
3,206,380 |
Premium* |
|
GeneDx Holdings Corp |
WGS |
Director |
2023-05-02 |
58,290 |
2023-05-02 |
113,145,535 |
Premium* |
|
Absci Corp |
ABSI |
Director |
2021-07-26 |
0 |
2021-07-26 |
973,260 |
Premium* |
|
Maxcyte, Inc. |
MXCT |
10% Owner |
2022-10-03 |
10,000,000 |
2021-07-30 |
0 |
Premium* |
|
Tenaya Therapeutics, Inc. |
TNYA |
Director, 10% Owner |
2021-08-03 |
0 |
2021-08-03 |
361,969 |
Premium* |
|
Cm Life Sciences Ii Inc. |
SLGC |
Director, 10% Owner |
2024-01-05 |
0 |
2024-01-05 |
0 |
Premium* |
|
EQRx, Inc. |
EQRX |
10% Owner |
2021-12-17 |
0 |
2023-11-09 |
0 |
Premium* |
|
Fluidigm Corp |
FLDM |
Director, 10% Owner |
2024-03-18 |
103,556 |
2024-03-18 |
25,431,856 |
Premium* |
|
2seventy Bio, Inc. |
TSVT |
Director |
2024-03-26 |
16,600 |
2024-03-26 |
2,000,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TSVT |
2seventy Bio, Inc. |
Director |
|
2024-03-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
16,600 |
|
- |
|
TSVT |
2seventy Bio, Inc. |
Director |
|
2024-03-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,182,623 |
|
- |
|
EXAS |
Exact Sciences Corp |
Director |
|
2018-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
6,262 |
6,262 |
0 |
- |
|
FULC |
Fulcrum Therapeutics, Inc... |
10% Owner |
|
2019-07-22 |
4 |
A |
$0.00 |
$0 |
I/I |
464,285 |
464,285 |
0 |
- |
|
EXAS |
Exact Sciences Corp |
Director |
|
2019-11-08 |
4 |
A |
$0.00 |
$0 |
I/I |
450 |
225 |
0 |
- |
|
GBIO |
Generation Bio Co. |
10% Owner |
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
961,215 |
961,215 |
0 |
- |
|
EXAS |
Exact Sciences Corp |
Director |
|
2020-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,558 |
8,820 |
0 |
- |
|
IPSC |
Century Therapeutics, Inc... |
Director |
|
2021-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
2,456,380 |
2,456,380 |
0 |
- |
|
WGS |
GeneDx Holdings Corp |
Director |
|
2021-07-22 |
4 |
A |
$0.00 |
$0 |
I/I |
10,993,750 |
10,993,750 |
0 |
- |
|
WGS |
GeneDx Holdings Corp |
Director |
|
2021-07-22 |
4 |
A |
$0.00 |
$0 |
I/I |
5,000,000 |
5,000,000 |
0 |
- |
|
ABSI |
Absci Corp |
Director |
|
2021-07-26 |
4 |
A |
$0.00 |
$0 |
I/I |
6,156,093 |
973,260 |
0 |
- |
|
TNYA |
Tenaya Therapeutics, Inc. |
Director |
|
2021-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
2,736,818 |
361,969 |
0 |
- |
|
BLFS |
Biolife Solutions Inc |
10% Owner |
|
2021-09-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
131,428 |
7,571,535 |
0 |
- |
|
BLFS |
Biolife Solutions Inc |
10% Owner |
|
2021-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
126,185 |
7,566,292 |
0 |
- |
|
SLGC |
Cm Life Sciences Ii Inc. |
Director |
|
2021-09-01 |
4 |
A |
$0.00 |
$25,000,000 |
I/I |
12,389,082 |
19,189,082 |
0 |
- |
|
SLGC |
Cm Life Sciences Ii Inc. |
Director |
|
2021-09-01 |
4 |
A |
$0.00 |
$0 |
I/I |
6,800,000 |
6,800,000 |
0 |
- |
|
EQRX |
EQRx, Inc. |
Director |
|
2021-12-17 |
4 |
A |
$0.00 |
$0 |
I/I |
8,659,372 |
8,659,372 |
0 |
- |
|
EQRX |
EQRx, Inc. |
Director |
|
2021-12-17 |
4 |
A |
$0.00 |
$50,000,000 |
I/I |
39,527,671 |
48,187,043 |
0 |
- |
|
EQRX |
EQRx, Inc. |
Director |
|
2021-12-17 |
4/A |
OE |
$0.00 |
$0 |
I/I |
8,659,372 |
8,659,372 |
0 |
- |
|
EQRX |
EQRx, Inc. |
Director |
|
2021-12-17 |
4/A |
D |
$0.00 |
$0 |
I/I |
(8,659,372) |
0 |
0 |
- |
|
EQRX |
EQRx, Inc. |
Director |
|
2021-12-17 |
4/A |
A |
$0.00 |
$50,000,000 |
I/I |
39,527,670 |
5,488,164 |
0 |
- |
|
SLGC |
Cm Life Sciences Ii Inc. |
Director |
|
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,430 |
3,430 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2022-04-04 |
4 |
A |
$0.00 |
$0 |
D/D |
15,852 |
15,852 |
0 |
- |
|
WGS |
GeneDx Holdings Corp |
Director |
|
2022-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,836 |
12,836 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
30,914 |
46,766 |
0 |
- |
|
68 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|